BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 10, 2001
View Archived Issues
Incara's porphyrin-based catalytic antioxidant is neuroprotective in ischemia
Read More
Dual PPAR agonist shows good preclinical results
Read More
Companies form strategic agreement to develop asthma and allergic rhinitis products
Read More
Preliminary animal studies indicate that Oxycyte may be safer than other PFC emulsions
Read More
Final results of PH-10 pilot study in the treatment of plaque psoriasis reported
Read More
Theratechnologies submits IND application to Health Canada for ThGRF1-44
Read More
Osteoarthritis product launched in Europe
Read More
Biora enters distribution agreement with USBiomaterials for new periodontal disease product
Read More
New selective dopamine D4 complete antagonist reported
Read More
Genetically modified neural stem cells may be useful in the treatment of PD
Read More
Avanir acquires technology to develop MIF modulators
Read More
Roche receives first approval for PEGASYS
Read More
Schering AG acquires rights to fasudil in the U.S. and Europe
Read More
Antalarmin inhibits stress-induced gastric ulceration in rats
Read More
New cathepsin and calpain inhibitors and their use described by Senju
Read More
Urokinase inhibitors with antiangiogenic activity reported by Abbott
Read More
Kyoto Pharmaceutical reports new derivatives with glucose- and triglyceride-lowering activity
Read More
Novel thrombin inhibitors presented by Akzo Nobel
Read More
Sumitomo describes new compounds for the treatment of inflammation and autoimmune diseases
Read More